Research development on drug resistance and mechanisms of Clostridium difficile

doi:10.3969/j.issn.1004-583X.2018.05.003

Clinical Focus

Previous Articles Next Articles

Research development on drug resistance and mechanisms of Clostridium difficile

1.Department of Infectious Diseases and Clinical Microbiology, Beijing Chaoyang Hospital,
Capital Medical University, Beijing 100020, China; 2.Department of Clinical Laboratory,
Bejing Key Laboratory for Mechanisms Research and Precision Diagnosis of Invasive Fungal Diseases,
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China

Online:2018-05-05 Published:2018-05-29
Contact: Corresponding author: Xiao Meng, Email: cjtcxiaomeng@aliyun.com

Abstract

Abstract: Clostridium difficile is the major cause of antibiotic associated diarrhea and hospital acquired infectious diarrhea. In developed countries and regions, C. difficile infections have high morbidity and mortality and have received broad attention. In comparison, China's data on C. difficile, especially on its resistance to commonly used antibiotics, is limited. Hence, this paper reviews the latest research progress on resistant status of C. difficile and its resistant mechanism.

Key words: Clostridium , difficile, drug resistance

Fan Xin1, Chen Xinfei2, Xiao Meng2, Xu Yingchun2. Research development on drug resistance and mechanisms of Clostridium difficile[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2018.05.003.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2018.05.003

https://huicui.hebmu.edu.cn/EN/Y2018/V33/I5/377

[1]	Guo Hao, Zhuang Huicui, Yang Limei, Ren Jing, Cui Dongsheng, Zhang Liran. 2019-2021 pathogen infection characteristics and drug resistance analysis on patients from Intensive Care Unit of the Hospital [J]. Clinical Focus, 2022, 37(6): 519-524.
[2]	Zhu Ying, Shu Qianqian, Chen Fuhui. Clinical characteristics and drug resistance of community-acquired Acinetobacter baumannii pneumonia [J]. Clinical Focus, 2022, 37(4): 315-319.
[3]	Li Shufan, Wang Yuxiu, Jiang Zhenghua. The correlation between the prognosis of lung adenocarcinoma with acquired resistance to the first-generation EGFR TKI and the T790M mutation [J]. Clinical Focus, 2022, 37(11): 985-991.
[4]	Peng Zhenli, Jiang Yao, Jia Lijuan, Wang Yanxin, Xue Weixiao, Shi Huiting. Analysis of pathogenic bacteria resistance and prognosis of bloodstream infection [J]. Clinical Focus, 2021, 36(8): 724-729.
[5]	Shen Ziyuan, Kang Haiquan, Sang Wei, Yan Dongmei. Analysis of bacterial distribution, resistance and risk factor of death of bacterial infection in leukemia patients [J]. Clinical Focus, 2021, 36(12): 1092-1096.
[6]	Yin Haiqing1a, Yao Baoguo2a, Chen Wanzhen1b, Su Li2b. Risk factors and drug resistance of Carbapenemresistant Enterobacter in malignant tumor patients [J]. Clinical Focus, 2020, 35(2): 166-169.
[7]	Li Xiaa, Ma Gaoxib, Hu Linglingc，Dong Fengmeib. Distribution and drug resistance of Streptococcus pneumoniae infection in children [J]. Clinical Focus, 2020, 35(2): 170-173.
[8]	Shi Youshan, Chen Tianhao. Pathogenic bacteria and etiological analysis of peritoneal dialysisassociated peritonitis in a single peritoneal dialysis center [J]. Clinical Focus, 2020, 35(11): 1010-1014.
[9]	Liu Qimeng, Ye Huan. Risk factors for Carbapenemresistant and mortality in inpatients with pneumonia due to gramnegative bacteria [J]. Clinical Focus, 2019, 34(4): 334-338.
[10]	Zhang Pan, Xie Shoujun, Wen Hainan. Distribution and drug resistance analysis of 1 113 strains of bloodstream infection [J]. Clinical Focus, 2019, 34(2): 148-153.
[11]	Li Yue, Qian Jiaming. Study advances of inflammatory bowel disease complicated with Clostridium difficile infection [J]. Clinical Focus, 2018, 33(5): 394-397.
[12]	Luo Yuxin, Han Fei, Zhang Ruimiao, Yin Fengrong. Epidemiology and risk factors of Clostridium difficile infection [J]. Clinical Focus, 2018, 33(5): 369-372.
[13]	Li Jing1， Liu Xiaolei2，Qiang Cuixin2， Shi Lei3， Zhao Jianhong2. graS gene and cell ultrastructure analysis of five methicillinresistant Staphylococcus aureus with reduced susceptibility to vancomycin [J]. Clinical Focus, 2017, 32(5): 405-408,412.
[14]	Wei Honglian, Yang Jing, Yuan Yin, Liu Yuehong, Shi Dongyan. Distribution and antimicrobial resistance surveillance of Pseudomonas aeruginosa isolates [J]. Clinical Focus, 2016, 31(2): 218-220.
[15]	Zhao Zhengbin1a，Fan Wenhai1b， Chen Qingfeng2，Yao Liqiong1a. Analysis of pathogen distribution and drug resistance in liver cirrhosis patient with spontaneous bacterial peritonitis [J]. Clinical Focus, 2016, 31(11): 1222-1224,1228.

Research development on drug resistance and mechanisms of Clostridium difficile

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments